SCHEMBL17087014

SCHEMBL17087014

C=C1[C@@H]2[C@H]3OC(=O)[C@@H](CC)[C@@H]3[C@@H](OC(=O)C(=O)CO)CC(=C)[C@@H]2C[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10099624 0.91 — —
SCHEMBL10099627 0.80 — —
Cynaropicrin SCHEMBL1711811 0.70 MAPT (0.42) —
Cynaropicrin SCHEMBL1711522 0.70 MAPT (0.42) —
Cynaropicrin SCHEMBL349976 0.70 MAPT (0.42) —
SCHEMBL10307519 0.69 MAPT (0.43) —
SCHEMBL10307583 0.68 MAPT (0.35) —
Aguerin B SCHEMBL29352650 0.68 MAPT (0.54) —
SCHEMBL29488633 0.66 MEN1 (0.33) —
SCHEMBL31092250 0.63 MAPT (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447112-B2 Use of parthenolide derivatives as antileukemic and cytotoxic agents UNIVERSITY OF KENTUCKY (US) 2016-09-20 — — US disclosed
US-20150259356-A1 USE OF PARTHENOLIDE DERIVATIVES AS ANTILEUKEMIC AND CYTOTOXIC AGENTS UNIV KENTUCKY (US) 2015-09-17 — — US disclosed
Send feedback